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The COP9 signalosome (CSN) complex is critical for mammalian cell proliferation and survival, but it
is not known how the CSN affects the cell cycle. In this study, MEFs lacking CSN5/Jab1 were gener-
ated using a CRE-ﬂox system. MEFs ceased to proliferate upon elimination of CSN5/Jab1. Rescue
experiments indicated that the JAMM domain of CSN5/Jab1 was essential. CSN5/Jab1-elimination
enhanced the neddylation of cullins 1 and 4 and altered the expression of many factors including
cyclin E and p53. CSN5/Jab1-elimination inhibited progression of the cell cycle at multiple points,
seemed to initiate p53-independent senescence and increased the ploidy of cells. Thus, CSN5/Jab1
controls different events of the cell cycle, preventing senescence and endocycle as well as the proper
progression of the somatic cell cycle.
Structured summary: MINT-8046253: Csn1 (uniprotkb:Q99LD4) physically interacts (MI:0914) with Csn5
(uniprotkb:O35864), Csn8 (uniprotkb:Q8VBV7), Csn3 (uniprotkb:O88543), Csn7b (uniprotkb:Q8BV13)
and Csn6 (uniprotkb:O88545) by anti bait coimmunoprecipitation (MI:0006)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The COP9 signalosome (CSN) complex is conserved basically in
all eukaryotic cells, and plays a pivotal role in cell proliferation and
survival [1,2]. In plants, the CSN acts as a repressor for photomor-
phogenesis, and is also critical for later development [3]. In mice,
the CSN is essential, and animals deﬁcient in CSN components
die at a very early stage of embryonic development [4].
The CSN consists of eight subunits (CSN1–8) and has multifunc-
tional roles [1], including regulation of the stability of cellular reg-
ulators through the control of the cullin-RING-E3 ligase (CRL) by
deneddylation [5–9]. The ﬁfth subunit (CSN5) is essential for this
activity. CSN5 contains a JAMM domain, critical for the isopepti-
dase catalytic activity by which the CSN removes the ubiquitin-like
modiﬁer Nedd8/Rub1 from the cullin subunit (deneddylation),
thereby regulating the activity of CRLs. However, CSN5 alone is
incapable of this activity, indicating that the holo-CSN complex is
required for this reaction.
Among the eight components of the CSN, CSN5 is unique in
many ways. CSN5 was originally identiﬁed as a protein binding
to the transcription factors c-Jun and JunD, and so also termed
Jun-activation-domain-binding protein (Jab) 1 [10]. CSN5/Jab1chemical Societies. Published by E
of Biological Sciences, Nara
ma, Ikoma, Nara 630-0101,was repeatedly isolated as an interactor of many factors regulating
signal transduction and cell proliferation/survival [4]. Besides the
CSN holo-complex, CSN5/Jab1 is also suggested to function as a
monomer or a smaller complex outside the CSN complex. How-
ever, the identity of the smaller form remains to be investigated.
During the last decade, substantial evidence has accumulated
showing that CSN5/Jab1 is an onco-protein [4]. First, CSN5/Jab1
is overexpressed in many human cancers. Among these tumors,
the CSN5/Jab1 gene itself is rarely mutated except for gene ampli-
ﬁcation in some cases, suggesting that the genetic target for malig-
nant transformation is the upstream regulators of CSN5/Jab1. A
high level of CSN5/Jab1 is often correlated with a poor prognosis.
Second, knockdown of CSN5/Jab1 inhibits the proliferation of hu-
man tumor cells [11,12], suggesting that overexpression of CSN5/
Jab1 not only serves as a marker of malignant transformation,
but also actually contributes to tumor cell proliferation. In fact, it
was shown that the CSN’s integrity was required for the growth
of Ras-transformed cells [13]. Third, ectopic expression of a stable
form of CSN5/Jab1 in mice induces the development of myelopro-
liferative disorders with expansion of the stem cell population [14].
Thus, CSN5/Jab1 functions in favor of cell proliferation/survival and
eventual tumorigenesis.
From the results obtained using CSN5/Jab1 knockout cells/mice
[15,16], it is clear that CSN5/Jab1 is essential for the proliferation
and survival of mammalian cells. CSN5/Jab1-null embryos ceased
to survive at a very early stage of development, in which elevated
levels of cyclin E, Cdk inhibitor p27, and tumor suppressor p53lsevier B.V. All rights reserved.
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point control. Conditional knockout of CSN5/Jab1 in T cells inhib-
ited progression through the S phase without signiﬁcant effects
on the G1 phase. Therefore, it remains to be clariﬁed how CSN5/
Jab1 functions for the proper progression of the mammalian cell
cycle.
In this study, we isolated MEFs harboring a conditional allele
(ﬂoxed) [16] of the CSN5/Jab1 gene. Introduction of the CRE recom-
binase into these cells efﬁciently inactivated the CSN5/Jab1 locus
and thereby eliminated the expression of CSN5/Jab1 protein. Using
this system, we analyzed the effect of CSN5/Jab1-elimination on
the progression of the cell cycle.2. Materials and methods
2.1. Mice and generation of MEFs
Mice harboring conditional (ﬂoxed, f) [16] and null () [15] al-
leles of the CSN5/Jab1 gene were generated as described previ-
ously. CSN5/Jab1+/f mice and CSN5/Jab1+/ mice were crossed and
CSN5/Jab1/f mice were obtained. Male and female CSN5/Jab1/f
mice were crossed and at day 13.5, embryos and embryonic ﬁbro-
blasts were isolated according to the standard procedure [15].
Genotypes were determined by PCR using high molecular DNA as
a template and a set of primers described previously [15,16].
2.2. Cell culture, transfection, and retroviral infection
Mouse embryonic ﬁbroblasts (MEFs) and 293T human
embryonic kidney (HEK) cells were cultured in Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM) supplemented with 10% fetal bo-
vine serum (FBS), 2 mM glutamine, 100 units/ml of penicillin,
and 100 lg/ml of streptomycin (GIBCO/BRL). For viral produc-
tion, MSCV-based expression vectors were co-transfected via
the calcium phosphate-DNA precipitation method [17] into
293T cells together with a plasmid encoding an ecotropic helper
virus containing a defective virion-packaging (w2) sequence.
Culture supernatants containing retroviruses harvested 48–72 h
after transfection were used to infect proliferating MEFs in the
presence of polybrene (4 lg/ml) [18]. For synchronization in
G0/G1, cells were incubated in medium containing 0.5% FBS
for 48 h.
2.3. Generation of CSN5/Jab1-mutants and plasmid construction
Nuclear export signal (NES)-mutant of CSN5/Jab1 was gener-
ated by converting three conserved leucine residues (positions
237, 240, and 241) in the NES motif to alanine residues (L237/
240/241A) by PCR-based mutagenesis as described [19]. JAMM do-
main mutant was generated by changing the conserved aspartic
acid residue in the His-X-His-X10-Asp motif (151st Asp in mice)
(codon GAT) [20] to asparagine (codon AAT) (D151N) by PCR using
following primers; sense 50-CTC CGG GAT TAA TGT TAG TAC-30 and
anti-sense 50-GTA CTA ACA TTA ATC CCG GAG-30. cDNA fragments
containing the coding sequence of CRE and wild-type/mutant
CSN5/Jab1 were subcloned into the pMSCV-ires-GFP vector (a gift
from Dr. Owen Witte).
2.4. Flow cytometric analysis
Cells were tripsinized and suspended in PBS. GFP signals were
measured with a FACScan ﬂow cytometer (Becton Dickinson).
GFP-positive cells were sorted with a FACSVantage cell sorter.
For the cell cycle analysis, cells were stained with a 1 ml solu-
tion of 0.1% sodium citrate and 0.1% Triton X-100 containing50 lg/ml of propidium iodide and treated with 1 lg/ml of RNase
for 30 min at room temperature. Fluorescence from the propidi-
um iodide-DNA complex was measured with a FACScan ﬂow
cytometer (Becton Dickinson), and the percentage of cells in
the sub-G1 population was determined with Modiﬁt cell cycle
software. The populations of dead cells were conﬁrmed by the
dye exclusion assay.
2.5. Protein analyses
Cell lysis, immunoprecipitation, sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis (SDS–PAGE), and immunoblotting
were performed as described [18,21]. In short, cells were washed
with PBS and lysed for 30 min on ice in modiﬁed EBC buffer
(50 mM Tris–HCl pH8.0, 120 mM NaCl, 1 mM EDTA, and 0.5%
NP40) containing 2000K IU/ml of aprotinin, 1 mM PMSF,
0.1 mM NaF, 0.1 mM Na3VO4, and 10 mM b-glycerophosphate.
The cell debris was removed by micro centrifugation at full
speed. The antibodies were reacted with cell lysate for 2 h to
overnight at 4 C. Immune complexes were collected by incuba-
tion with protein A or protein G Sepharose beads for 2 h at 4 C,
and boiled in SDS-sample buffer (40 mM Tris–HCl, pH 6.8, 0.1 M
DTT, 1% SDS, 10% glycerol, and 0.05% bromophenol blue) for
4 min. To prepare direct lysate for immunoblotting, cell lysate
in a EBC buffer was mixed with the same amount of 2X SDS-
sample buffer (80 mM Tris–HCl, pH 6.8, 0.2 M DTT, 2% SDS,
20% glycerol, and 0.1% bromophenol blue) and boiled for
4 min. Protein samples were separated on SDS–polyacrylamide
gels under reducing conditions (SDS–PAGE), transferred to a
nitrocellulose membrane or a PVDF membrane (Milipore), and
immunoblotted with the antibodies indicated. Proteins were de-
tected with the ECL blotting system (Amersham) according to
the manufacturer’s instructions. Developed ﬁlms were quantita-
tively analyzed with a densitograph (ATTO, Japan).
For non-denaturing gel electrophoresis (native-PAGE) [22], cells
were lysed in a digitonin-lysis buffer (50 mM Tris–HCl, pH 8.0,
120 mM NaCl, 1 mM EDTA, and 0.1% digitonin) at 1  105 cells/ll
(more than 1  107 cells were required for quantitative, reproduc-
ible native-PAGE analysis). Equal amounts (ca. 100 lg) of total pro-
tein were separated on precast native gradient gels (5–15%; Bio-
Craft, Tokyo, Japan) without sodium dodecyl sulfate (SDS) at
5 mA for 16 h followed by 10 mA for 6 h, and analyzed by immuno-
blotting using antibody to CSN5/Jab1.
Rabbit polyclonal antibodies to the CSN subunits, Cul1 and 4,
p53, p21, and Skp2 were generated using bacterially produced
polypeptides in our laboratory. A rabbit polyclonal antibody to
Geminin was provided by Dr. Yoshihiro Takihara. Mouse monoclo-
nal antibodies to cyclin D1 (72–13G) and Cdc2 (17) and rabbit
polyclonal antibodies to Skp2 (H-435), p16 (M156), cyclin E
(M20), cyclin A (C19), Cdk2 (M2), and Cdk4 (C22) were obtained
from Santa Cruz. A mouse monoclonal antibody to c-tubulin
(GTU88) was purchased from Sigma.
2.6. Immunoﬂuorescence staining
Cells grown on coverslips were ﬁxed in 4% paraformaldehyde.
Chromosomal DNA was stained by incubation in 1 lg/ml of Hoe-
chst 33342 for 2 min. The samples were viewed by phase-contrast
or ﬂuorescence microscopy.
For the determination of BrdU incorporation, cells incubated in
10 lM bromodeoxyuridine (BrdU) for 15 min were treated with
1.5 M HCl and stained with anti-BrdU mouse monoclonal antibody
(Amersham Biosciences) and ﬂuorescein isothiocyanate-linked
anti-mouse IgG. The cell samples were viewed by phase contrast
or ﬂuorescence microscopy. More than 500 cells were enumerated
for each sample.
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Cells were ﬁxed in 0.25% glutaraldehyde, incubated for 16–24 h
in X-gal solution containing 0.2% X-gal, 2 mM MgCl2, 5 mM
K4Fe(CN)6, and 5 mM K3Fe(CN)6, and viewed with a phase-contrast
microscope.
3. Results
3.1. Conditional knockout of the CSN5/Jab1 gene in mouse embryonic
ﬁbroblasts (MEFs)
Because previous studies showed that CSN5/Jab1/ mice died
in the embryonic stage [15] and the depletion of CSN5/Jab1 pre-
vented cell proliferation [11,12], we decided to utilize the condi-
tional allele (ﬂoxed) of CSN5/Jab1 [16] (Fig. 1A) to analyze the
effect of CSN5/Jab1 depletion simultaneously. CSN5/Jab1+/ mice
were crossed with CSN5/Jab1+/f mice, generating CSN5/Jab1/f
mice. From the embryos obtained by crossing CSN5/Jab1/f males
and females, we isolated MEFs harboring the CSN5/Jab1/f
genotype.
To achieve a high efﬁciency of gene transduction, we generated
a CRE retroviral vector by inserting cDNA encoding a CRE recombi-
nase into a retroviral vector, MSCV-ires-GFP (a gift from Dr. Owen
Witte, UCLA), and transfected it into 293T cells together with help-
er viral DNA lacking the packaging signal sequence. The resultingFig. 1. Conditional knockout of the CSN5/Jab1 locus. (A) Schematic diagram of the wild-t
weight DNA was isolated from MEFs harboring the CSN5 locus shown at the top and use
[15,16] to determine the genotype. (C) Lysates were isolated from CSN5/Jab1/f MEFs infe
using antibodies against CSN5/Jab1 and c-tubulin. (D) Right panels; Lysates were isolat
infection. The CSN complex was immunorecipitated from the lysate using antibody to the
shown at the right of the panels. (Left panel) The direct lysates were immunoblotted wretrovirus was used to infect CSN5/Jab1/f MEFs. Uninfected cells
were removed by cell sorting.
Fig. 1B shows that the introduction of CRE efﬁciently inacti-
vated the ﬂoxed allele of the CSN5/Jab1 gene. Because CSN5/
Jab1-depletion effectively prevented cell proliferation and sur-
vival (see below), and it is reported that conditional knockout
of the CSN5/Jab1 gene in mice allowed cells in which CSN5/
Jab1-knockout was not successful to prevail in the end [16],
we used the CSN5/Jab1/f allele rather than the CSN5/Jab1f/f al-
lele to achieve higher efﬁciency, but basically the same results
were obtained when either allele was used. Upon conversion of
the CSN5/Jab1 ﬂoxed allele, the expression of CSN5/Jab1 protein
was eliminated as well (Fig. 1C). At the later stage (ca. 1 week)
after CSN5/Jab1-depletion, other CSN subunits were also down-
regulated (see below). However, at the very early stages (2–
4 days) of infection by the CRE virus, expression of the most
CSN subunits were sustained (Fig. 1D). Our antibody to CSN1
efﬁciently recognizes the holo-CSN complex and, in fact, anti-
CSN1 immunoprecipitates contained other CSN components
(Fig. 1D, left panel, and see Ref. [19]). Interestingly, CSN5/Jab1-
depletion at the very early stages minimally affected the amount
of other CSN components in the anti-CSN1 immunoprecipitates
(Fig. 1D), indicating that CSN subunits formed a complex with-
out CSN5/Jab1. However, this complex seemed unstable and
CSN5/Jab1-depletion eventually led to the decrease in expression
of other CSN subunits (see below).ype (WT) and modiﬁed (Floxed, Floxed + Cre, KO) CSN5/Jab1 loci. (B) High molecular
d as a template. Genomic PCR was performed using primers as described previously
cted with control (GFP) and CRE (GFP/CRE) viruses and analyzed by immunoblotting
ed from CSN5/Jab1/f MEFs infected with GFP and GFP/CRE viruses at day 3 post-
CSN1 subunit and analyzed by immunoblotting using antibodies to the CSN subunit
ith antibody to c-tubulin to show the equal loading.
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of the JAMM domain is important
CSN5/Jab1-depletion (CSN5/Jab1/f allele + CRE) markedly
inhibited cell proliferation, whereas introduction of the CRE
recombinase itself had little effect because wild-type MEFs in-
fected with the CRE virus grew normally compared with control
MEFs (Fig. 2A and B). The negative effect of CRE on cell growth
was speciﬁc to the elimination of CSN5/Jab1 because ectopic intro-
duction of wild-type CSN5/Jab1 rescued the proliferative defect of
CSN5/Jab1/f + CRE (Fig. 2B–D). In this assay, the JAMM-mutant
(D151N) form of CSN5/Jab1 [20] failed, whereas the NES-mutant
(L237/240/241A) form of CSN5/Jab1 [19] was as effective as the
wild type. In these transfectants, the excision of endogenous ﬂoxed
alleles was equally effective (Fig. 2C) and expression levels of ecto-
pic CSN5/Jab1 proteins (wild type, and JAMM and NES mutants)
were equivalent (Fig. 2D). Analysis by native-PAGE and immuno-
blotting (Fig. 2D, the bottom panel) revealed that ectopically-ex-
pressed CSN5/Jab1 was efﬁciently incorporated into the CSN-holo
complex (Only the results with wild-type and NES mutant CSN5/
Jab1 were shown. Because the amount of cells expressing both
CRE and JAMM mutant CSN5/Jab1 was not sufﬁcient for the analy-
sis, we were unable to perform the native-PAGE analysis). These
results imply that the isopeptidase activity of the CSN-holo com-
plex is critical for mammalian cell proliferation.
After the introduction of CRE into CSN5/Jab1/f MEFs, a small
number of GFP-positive colonies sometimes grew up after a long
interval. These cells, however, retained the undisturbed ﬂoxed al-
lele of CSN5/Jab1, suggesting that expression of and/or recombina-Fig. 2. CSN5/Jab1-depletion prevented cell proliferation. (A) and (B) Wild-type (A, WT) a
GFP, CRE (GFP/CRE), wild-type CSN5/Jab1 (WT), and CSN5/Jab1 containing mutations in t
plated (1  104 cells), and enumerated daily for 4 days. (C) HMWDNAs isolated fromMEF
in Fig. 1B. (D) Lysates were isolated from CSN5/Jab1/f MEFs infected with the viruses in
panel) and analyzed by immunoblotting using antibodies against CSN5/Jab1 (top and bott
complex (containing CSN5/Jab1) was shown. Because the amount of cells was not sufﬁcie
with CRE- and DJAMM-viruses.tion by CRE had somehow failed in these cells. We were
unsuccessful in the isolation of revertant clones from the CSN5/
Jab1-inactivated population of MEFs even after several trials,
implying that loss of the CSN activity affects many factors and
pathways, and few cellular mutations can recover the loss of the
CSN.
3.3. Depletion of CSN5/Jab1 prevented proper progression of the cell
cycle at multiple points
Consistent with the growth suppression induced by the loss of
CSN5/Jab1, CSN5/Jab1-depleted cells eventually died (mostly from
2 weeks after depletion) and ectopic expression of wild-type CSN5/
Jab1 rescued the defect (Fig. 3A). At the relatively early stage (4–
6 days) of infection by the CRE virus, however, most cells were still
alive and we analyzed their DNA content by ﬂow cytometer. Fig. 3B
summarizes that introduction of CRE slightly decreased the popu-
lation of cells in the G1 and S phases, slightly increased that of cells
in the G2/M phase and markedly increased that of cells with higher
ploidy (>4n) (see Fig. 3C, right panel for example). Microscopic
observation revealed that cells with higher ploidy frequently con-
tained more than one nucleus (Fig. 3C). (They also exhibited a
senescence-associated heterochromatin foci (SAHF)-like structure
(Fig. 3C, middle panel). See below.) Interestingly, serum-deprived
medium failed to cause cells to markedly accumulate in the G0/
G1 phase (Fig. 3B, 4th (31%) versus 6th (37%) columns), whereas
wild-type cells were efﬁciently accumulated into the G0/G1 popu-
lation (Fig. 3B 3rd (46%) versus 7th (86%) columns), indicating that
CSN5/Jab1-depletion inhibited progression of the cell cycle atnd CSN5/Jab1/f (B, CSN5-/f) MEFs were infected with retroviruses encoding control
he NES sequence (DNES, L237/240/241A) or in the JAMM domain (DJAMM, D151N),
s infected with retroviral vectors were subjected to a genomic PCR analysis as shown
dicated, separated by SDS–PAGE (top and middle panels) and native-PAGE (bottom
om panels) and c-tubulin (middle panel). Native-PAGE: the position of the CSN-holo
nt, we were unable to perform the native-PAGE analysis for the cells doubly infected
Fig. 3. CSN5/Jab1-depletion inhibited progression of the cell cycle at multiple points. (A) Wild-type (WT) and CSN5/Jab1/f (CSN5/f) MEFs were infected with viral vectors
encoding GFP, CRE (GFP/CRE), and wild-type CSN5/Jab1 (WT). At 2 weeks post-infection, cells were analyzed by ﬂowcytometer. Percentages of apoptotic cells were
determined from the population of cells in subG1. (B) MEFs infected as in panel A were analyzed by ﬂowcytometer at day 6 post-infection. In some cases (-FBS), cells were
cultured in serum-deprived (0.5% FBS) medium for 48 h before analysis. (C) MEFs infected and cultured as in panel B were photographed after staining with Hoechst 33342
(left panels), or treated with PI and subjected to a ﬂowcytometric analysis (right panels). The cells stained with Hoechst 33342 and exhibiting a SAHF-like structure were
enumerated (middle panel) (*P < 0.0005). (D) and (E) CSN5/Jab1/f (CSN5/f) MEFs infected with viral vectors encoding GFP and CRE (GFP/CRE) were subjected to BrdU
incorporation assays at day 6 post-infection. Photos (D) and a summary of the results (E) are shown. *P < 0.0001. (F) CSN5/Jab1/f MEFs infected with control GFP and CRE
(GFP/CRE) viruses were cultured with GFP-negative cells at a 1:1 ratio and the GFP-positive population was enumerated at days 4, 7, and 10.
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expression of wild-type CSN5/Jab1.
To examine whether the elimination of CSN5/Jab1 affects pro-
gression through the S phase, we performed a pulse-labeling BrdU
incorporation assay using cells at the relatively early stage (6 days)
of infection by the CRE virus. Fig. 3D and E shows that CSN5/Jab1-
depletion markedly inhibited BrdU incorporation (basically littleincorporation above the background), indicating that cells with a
DNA content of between 2n and 4n did not progress through the
S phase after the inactivation of CSN5/Jab1.
Finally, we investigated the effect of the surrounding environ-
ment on suppression of the cell growth of CSN5/Jab1-depleted
cells. CSN5/Jab1/f MEFs infected with the CRE virus were cultured
with CRE-negative cells at a 1:1 ratio and the percentage of GFP-
Fig. 4. CSN5/Jab1-depletion altered the expression level of many cell cycle
regulators. Lysates from CSN5/Jab1/f MEFs infected with control (GFP) and CRE
(GFP/CRE) viruses were analyzed at day 6 post-infection by immunoblotting using
the antibodies shown above the panels.
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(Fig. 3F). GFP-control cells proliferated at the same rate as the sur-
rounding GFP-negative cells for 10 days, while CSN5/Jab1-depletedFig. 5. Effects of CSN5/Jab1-depletion were independent of p53 function. CSN5/Jab1/f p
and D) At 6 days post-infection, cells were stained with Hoechst 33342 (C) and for b-gala
and observed under phase-contrast (A and D) and ﬂuorescent (C) microscopes. The cells
(D, right panel, *P < 0.0001) were enumerated. (B) Alternatively, cells were subjected tocells were gradually eliminated from the culture. These results
indicate that it is not due to the insufﬁcient release of the factors
from the CSN5/Jab1-depleted cells into the culture medium (or
insufﬁcient contact between cells), but most probably due to a de-
fect of the intracellular mechanism regulating progression of the
cell cycle.
3.4. CSN5/Jab1 affected the expression of many cell cycle regulators
To explore the mechanism by which CSN5/Jab1-depletion pre-
vents progression of the cell cycle, we analyzed the lysates isolated
from CSN5/Jab1/f MEFs infected with control GFP and GFP/CRE
viruses at day 6 post-infection by immunoblotting with antibodies
against various cell cycle regulators (Fig. 4). Accompanying the
elimination of CSN5/Jab1, levels of other CSN subunits markedly
declined (CSN1 and 3 are shown in Fig. 4). However, the reduction
in levels of other subunits was signiﬁcantly less than that for CSN5/
Jab1, suggesting the existence of a CSN subcomplex that does not
contain CSN5/Jab1, or alternatively, the existence of a small com-
plex/monomeric form outside the CSN-holo complex. In fact, at
the very early stages (2–4 days) after CSN5/Jab1-depletion, CSN
subunits formed a subcomplex without CSN5/Jab1 (Fig. 1D, see
above).
Signiﬁcant amounts of Cul1 and Cul4 proteins were converted
to a neddylated form (slower-migrating form) in the absence of
CSN5/Jab1 (Fig. 4), consistent with the fact that CSN5/Jab1 is a cat-
alytic subunit for the isopeptidase (deneddylase) activity in the
CSN complex. In CSN5/Jab1-depleted cells, we observed the upreg-
ulation of many factors partly due to inactivation of CRL, including
cyclins D1, A and E, Cdk2, Cdc2, p16, and Geminin (Fig. 4). The level
of Skp2 was not signiﬁcantly changed.53/ MEFs were infected with viral vectors encoding GFP and CRE (GFP/CRE). (A, C
ctosidase (D, for the positive control, wild-type MEFs in the late passage were used)
exhibiting a SAHF-like structure (C, right panel, *P < 0.0005) and b-gal-positive cells
a cell cycle analysis as in Fig. 3B.
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independent of the function of p53
We observed an upregulation of the expression of the tumor
suppressor p53 together with its target gene product p21 in
CSN5/Jab1-depleted MEFs (Fig. 4). This is the anticipated result be-
cause CSN5/Jab1-null embryos contained high levels of p53 [15].
To examine whether the defect of cell cycle progression induced
by CSN5/Jab1-depletin is mediated by the p53 pathway, we
crossed CSN5/Jab1/f mice with p53 knockout mice and eventually
isolated MEFs exhibiting the CSN5/Jab1/f p53/ genotype. We in-
fected CSN5/Jab1/f p53/ MEFs with the CRE virus and analyzed
the cell proliferation phenotype. At 2 weeks post infection of the
CRE/GFP virus, we found few colonies of MEFs with GFP signals.
Microscopic observation of cells at an earlier stage showed that
they were ﬂat with little sign of proliferation, and, later, all died.
We frequently found multi-nuclear cells in the CRE-infected cul-
ture but not in the control culture (Fig. 5A). Flow cytometric anal-
ysis showed that G1 and S phase cells were decreased, G2/M phase
cells were slightly increased, and the population of cells with high-
er ploidy was markedly increased (Fig. 5B). In addition, nuclear
staining with the Hoechst dye revealed that a signiﬁcant popula-
tion of CSN5/Jab1-depleted cells exhibited a senescence-associated
heterochromatin foci (SAHF)-like structure in the absence (Fig. 5C)
and presence (Fig. 3C, middle panel) of p53, suggesting that CSN5/
Jab1-depletion initiated a senescence program without the func-
tioning of p53 (other senescence-associated markers are an in-
crease in p21 and p16 proteins (Fig. 4) for p53+/+ cells, and
induction of the b-gal activity (Fig. 5D) for p53/ cells).
4. Discussion
It has been shown that the activity of the CSN holo-complex or
function of the CSN5/Jab1 subunit is critical to the proliferation of
mammalian cells. CSN5/Jab1 knockout mice ceased to develop at a
very early stage of embryogenesis [15]. CSN5/Jab1 knockdown in
cancer cells inhibited proliferation in culture [11,12]. Conditional
knockout of CSN5/Jab1 in T cells prevented cell proliferation [16].
However, it remained to be clariﬁed precisely how the loss of
CSN5/Jab1 affects the mammalian cell cycle. In this study, we took
advantage of the conditional allele of the CSN5/Jab1 gene and
simultaneously deleted the gene from cultured MEFs in vitro by
introducing a CRE recombinase. We ﬁrst conﬁrmed that CSN5/
Jab1 is indispensable for mammalian cell proliferation, and found
that progression of multiple phases of the cell cycle was inhibited,
implying that CSN5/Jab1 functions at multiple points during the
cycle. To preclude the inﬂuence of cellular senescence in an
in vitro culture, we used naturally immortalized MEFs and p53/
 MEFs, which never enter senescence, as well as the primary
MEF culture, and obtained the same results. This ﬁnding is consis-
tent with reports that (1) CSN5/Jab1+/ MEFs exhibited a delay in
progression from the G0 to S phase [15], (2) CSN5/Jab1/ T cells
showed a defect in S phase progression [16], and (3) CSN5/Jab1 tar-
gets multiple cell cycle regulators (from the G1 to M phase) such as
p27, cyclin E, p53, DNA topoisomerase II, and APC/C (see [4] for re-
view). Thus, we conclude that CSN5/Jab1 controls multiple cell cy-
cle events from the G1 to M phase.
In addition, we found that a signiﬁcant population of CSN5/
Jab1-depleted MEFs showed an increase in ploidy. DNA content
ranged from 4n to 8n and microscopic observation revealed that
the culture contained many multi-nuclear cells, suggesting that
CSN5/Jab1 regulates cytokinesis and/or endoreplication. In fact, it
was reported that the CSN activity is connected with the endocycle
in plants [3,23], and we previously observed that, in CSN5/Jab1-
knocked out embryos, trophoblasts, which undergo endoreplica-tion, remained intact, whereas the proliferation and survival of
ICM (Inner Cell Mass), which go through the somatic cell cycle,
were more severely inhibited [15].
The machinery regulating endoreplication in the mammalian
system remains poorly understood though the activity associated
with cyclin E [24] and APC/C [25] may play a role. It is worth noting
that in CSN5/Jab1-depleted cells, cyclin E expression is upregulated
and this could be partly responsible for the aberrant entry into the
endocycle. However, this could not be the sole reason because (1)
overexpression of cyclin E alone did not induce endoreplication
[26], and (2) knockdown of Cdk2 did not reverse the increase in
ploidy in CSN5/Jab1-depleted cells (unpublished observation, AY,
NYK, and JYK). Thus, the mechanism regulating entry into the
endocycle in mammals largely remains a mystery, and the CSN5/
Jab1-depletein system may be a good tool to investigate this
phenomenon.
Finally, DNA staining revealed that a signiﬁcant population of
cells exhibited a SAHF-like structure, suggesting that CSN5/Jab1
may regulate cellular senescence. This functioned in the absence
of p53 and occurred with no signiﬁcant change in the level of
Skp2, which was recently implicated in the regulation of senes-
cence [27], suggestive of a novel mechanism inducing proliferative
senescence. In conclusion, we propose that CSN5/Jab1 is a modula-
tor of the mammalian cell cycle (somatic cell cycle/endocycle/
senescence).
Acknowledgements
We thank Ms. I. Nakamae for excellent technical assistance. This
work was partly supported by Grants-in-Aid for Scientiﬁc Research
and for Cancer Research from the Ministry of Education, Science,
and Culture of Japan.
References
[1] Wei, N. and Deng, X.W. (2003) The COP9 signalosome. Annu. Rev. Cell Dev.
Biol. 19, 261–286.
[2] Wei, N. and Deng, X.W. (1999) Making sense of the COP9 signalosome. A
regulatory protein complex conserved from Arabidopsis to human. Trends
Genet. 15, 98–103.
[3] Schwechheimer, C. and Isono, E. (2010) The COP9 signalosome and its role in
plant development. Eur. J. Cell Biol. 89, 157–162.
[4] Kato, J.Y. and Yoneda-Kato, N. (2009) Mammalian COP9 signalosome. Genes
Cells 14, 1209–1225.
[5] Schwechheimer, C. and Deng, X.W. (2001) COP9 signalosome revisited: a novel
mediator of protein degradation. Trends Cell Biol. 11, 420–426.
[6] Bech-Otschir, D., Seeger, M. and Dubiel, W. (2002) The COP9 signalosome: at
the interface between signal transduction and ubiquitin-dependent
proteolysis. J. Cell Sci. 115, 467–473.
[7] von Arnim, A.G. (2003) On again-off again: COP9 signalosome turns the key on
protein degradation. Curr. Opin. Plant Biol. 6, 520–529.
[8] Cope, G.A. and Deshaies, R.J. (2003) COP9 signalosome: a multifunctional
regulator of SCF and other cullin-based ubiquitin ligases. Cell 114, 663–671.
[9] Wolf, D.A., Zhou, C. and Wee, S. (2003) The COP9 signalosome: an assembly
and maintenance platform for cullin ubiquitin ligases? Nat. Cell Biol. 5, 1029–
1033.
[10] Claret, F.X., Hibi, M., Dhut, S., Toda, T. and Karin, M. (1996) A new group of
conserved coactivators that increase the speciﬁcity of AP-1 transcription
factors. Nature 383, 453–457.
[11] Adler, A.S., Lin, M., Horlings, H., Nuyten, D.S., van de Vijver, M.J. and Chang,
H.Y. (2006) Genetic regulators of large-scale transcriptional signatures in
cancer. Nat. Genet. 38, 421–430.
[12] Fukumoto, A., Tomoda, K., Yoneda-Kato, N., Nakajima, Y. and Kato, J.Y. (2006)
Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines. FEBS
Lett. 580, 5836–5844.
[13] Luo, J., Emanuele, M.J., Li, D., Creighton, C.J., Schlabach, M.R., Westbrook, T.F.,
Wong, K.K. and Elledge, S.J. (2009) A genome-wide RNAi screen identiﬁes
multiple synthetic lethal interactions with the Ras oncogene. Cell 137, 835–
848.
[14] Mori, M., Yoneda-Kato, N., Yoshida, A. and Kato, J.Y. (2008) Stable form of JAB1
enhances proliferation and maintenance of hematopoietic progenitors. J. Biol.
Chem. 283, 29011–29021.
[15] Tomoda, K., Yoneda-Kato, N., Fukumoto, A., Yamanaka, S. and Kato, J.Y. (2004)
Multiple functions of jab1 are required for early embryonic development and
growth potential in mice. J. Biol. Chem. 279, 43013–43018.
4552 A. Yoshida et al. / FEBS Letters 584 (2010) 4545–4552[16] Panattoni, M. et al. (2008) Targeted inactivation of the COP9 signalosome
impairs multiple stages of T cell development. J. Exp. Med. 205, 465–477.
[17] Chen, C. and Okayama, H. (1987) High-efﬁciency transformation of
mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752.
[18] Yoneda-Kato, N., Tomoda, K., Umehara, M., Arata, Y. and Kato, J.Y. (2005)
Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9
signalosome subunit 3. EMBO J. 24, 1739–1749.
[19] Tomoda, K. et al. (2002) The cytoplasmic shuttling and subsequent
degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome
complex. J. Biol. Chem. 277, 2302–2310.
[20] Cope, G.A., Suh, G.S., Aravind, L., Schwarz, S.E., Zipursky, S.L., Koonin, E.V. and
Deshaies, R.J. (2002) Role of predicted metalloprotease motif of Jab1/Csn5 in
cleavage of Nedd8 from Cul1. Science 298, 608–611.
[21] Kato, J.Y., Nakamae, I., Tomoda, K., Fukumoto, A. and Yoneda-Kato, N. (2006)
Preparation and characterization of monoclonal antibodies against mouse
Jab1/CSN5 protein. Hybridoma (Larchmt) 25, 342–348.
[22] Tomoda, K., Kato, J.Y., Tatsumi, E., Takahashi, T., Matsuo, Y. and Yoneda-Kato,
N. (2005) The Jab1/COP9 signalosome subcomplex is a downstream mediatorof Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood 105,
775–783.
[23] Dohmann, E.M., Levesque, M.P., De Veylder, L., Reichardt, I., Jurgens, G.,
Schmid, M. and Schwechheimer, C. (2008) The Arabidopsis COP9 signalosome
is essential for G2 phase progression and genomic stability. Development 135,
2013–2022.
[24] Eliades, A., Papadantonakis, N. and Ravid, K. (2010) New roles for cyclin E in
megakaryocytic polyploidization. J. Biol. Chem. 285, 18909–18917.
[25] Zielke, N., Querings, S., Rottig, C., Lehner, C. and Sprenger, F. (2008) The
anaphase-promoting complex/cyclosome (APC/C) is required for rereplication
control in endoreplication cycles. Genes Dev. 22, 1690–1703.
[26] Arata, Y., Fujita, M., Ohtani, K., Kijima, S. and Kato, J.Y. (2000) Cdk2-dependent
and -independent pathways in E2F-mediated S phase induction. J. Biol. Chem.
275, 6337–6345.
[27] Lin, H.K. et al. (2010) Skp2 targeting suppresses tumorigenesis by Arf-p53-
independent cellular senescence. Nature 464, 374–379.
